Thrombopoietin	B-protein
induces	O
tyrosine	O
phosphorylation	O
of	O
Stat3	B-protein
and	O
Stat5	B-protein
in	O
human	B-cell_type
blood	I-cell_type
platelets	I-cell_type
.	O

Thrombopoietin	B-protein
is	O
known	O
to	O
be	O
essential	O
for	O
megakaryocytopoiesis	O
and	O
thrombopoiesis	O
.	O

Recently	O
,	O
we	O
and	O
others	O
have	O
shown	O
that	O
thrombopoietin	B-protein
induces	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
Jak2	B-protein
and	O
other	O
proteins	O
in	O
human	B-cell_type
platelets	I-cell_type
and	O
BaF3	B-cell_line
cells	I-cell_line
,	O
genetically	O
engineered	O
to	O
express	O
c-Mpl	B-protein
,	O
a	O
receptor	O
for	O
thrombopoietin	B-protein
.	O

The	O
Jak	O
family	O
of	O
tyrosine	B-protein
kinases	I-protein
are	O
known	O
to	O
mediate	O
some	O
of	O
the	O
effects	O
of	O
cytokines	B-protein
or	O
hematopoietic	B-protein
growth	I-protein
factors	I-protein
by	O
recruitment	O
and	O
tyrosine	O
phosphorylation	O
of	O
a	O
variety	O
of	O
Stat	B-protein
(	O
signal	B-protein
transducers	I-protein
and	I-protein
activators	I-protein
of	I-protein
transcription	I-protein
)	O
proteins	O
.	O

Hence	O
,	O
we	O
have	O
investigated	O
whether	O
Stat	B-protein
proteins	I-protein
are	O
present	O
in	O
platelets	B-cell_type
and	O
,	O
if	O
so	O
,	O
whether	O
they	O
become	O
tyrosine	O
phosphorylated	O
in	O
response	O
to	O
thrombopoietin	B-protein
.	O

We	O
immunologically	O
identified	O
Stat1	B-protein
,	O
Stat2	B-protein
,	O
Stat3	B-protein
,	O
and	O
Stat5	B-protein
in	O
human	O
platelet	O
lysates	O
.	O

Thrombopoietin	B-protein
induced	O
tyrosine	O
phosphorylation	O
of	O
Stat3	B-protein
and	O
Stat5	B-protein
in	O
these	O
cells	O
.	O

Thrombopoietin	B-protein
also	O
induced	O
tyrosine	O
phosphorylation	O
of	O
Stat3	B-protein
and	O
Stat5	B-protein
in	O
FDCP-2	B-cell_line
cells	I-cell_line
genetically	O
engineered	O
to	O
constitutively	O
express	O
human	B-protein
c-Mpl	I-protein
.	O

Thus	O
,	O
our	O
data	O
indicate	O
that	O
Stat3	B-protein
and	O
Stat5	B-protein
may	O
be	O
involved	O
in	O
signal	O
transduction	O
after	O
ligand	O
binding	O
to	O
c-Mpl	B-protein
and	O
that	O
this	O
event	O
may	O
have	O
a	O
role	O
in	O
megakaryopoiesis/thrombopoiesis	O
or	O
possibly	O
a	O
mature	O
platelet	O
function	O
such	O
as	O
aggregation	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RAPID	NULL
COMMUNICATION	NULL
Thrombopoietin	NULL
Induces	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
Stat3	NULL
and	NULL
Stat5	NULL
in	NULL
Human	NULL
Blood	NULL
Platelets	NULL
By	NULL
Yoshitaka	NULL
Miyakawa	NULL
,	NULL
Atsushi	NULL
Oda	NULL
,	NULL
Brian	NULL
J.	NULL
Druker	NULL
,	NULL
Hiroshi	NULL
Miyazaki	NULL
,	NULL
Makoto	NULL
Handa	NULL
,	NULL
Hideya	NULL
Ohashi	NULL
,	NULL
and	NULL
Yasuo	NULL
Ikeda	NULL
Thrombopoietin	NULL
is	NULL
known	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
megakaryocytopoiesis	NULL
and	NULL
thrombopoiesis	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
thrombopoietin	NULL
induces	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
and	NULL
other	NULL
proteins	NULL
in	NULL
human	NULL
platelets	NULL
and	NULL
BaF3	NULL
cells	NULL
,	NULL
genetically	NULL
engineered	NULL
to	NULL
express	NULL
c-Mpl	NULL
,	NULL
a	NULL
receptor	NULL
for	NULL
thrombopoietin	NULL
.	NULL

The	NULL
Jak	NULL
family	NULL
of	NULL
tyrosine	NULL
kinases	NULL
are	NULL
known	NULL
to	NULL
mediate	NULL
some	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
cytokines	NULL
or	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
by	NULL
recruitment	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
Stat	NULL
(	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
)	NULL
proteins	NULL
.	NULL

Hence	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
whether	NULL
Stat	NULL
proteins	NULL
are	NULL
present	NULL
in	NULL
platelets	NULL
and	NULL
,	NULL
if	NULL
so	NULL
,	NULL
whether	NULL
they	NULL
become	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
LONING	NULL
OF	NULL
A	NULL
cDNA	NULL
for	NULL
thrombopoietin	NULL
has	NULL
enabled	NULL
us	NULL
to	NULL
perform	NULL
an	NULL
extensive	NULL
examination	NULL
of	NULL
the	NULL
biologic	NULL
functions	NULL
of	NULL
this	NULL
hematopoietic	NULL
growth/maturation	NULL
factor	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
thrombopoietin	NULL
induces	NULL
the	NULL
growth	NULL
and	NULL
maturation	NULL
of	NULL
megakaryocytic	NULL
precursors	NULL
.	NULL
``	NULL

In	NULL
support	NULL
of	NULL
this	NULL
conclusion	NULL
,	NULL
mice	NULL
lacking	NULL
c-Mpl	NULL
(	NULL
a	NULL
receptor	NULL
for	NULL
thrombopoietin	NULL
)	NULL
have	NULL
significantly	NULL
reduced	NULL
numbers	NULL
of	NULL
circulating	NULL
platelets	NULL
.	NULL
``	NULL

Despite	NULL
extensive	NULL
knowledge	NULL
of	NULL
thrombopoietin	NULL
function	NULL
,	NULL
the	NULL
intracellular	NULL
events	NULL
that	NULL
occur	NULL
after	NULL
thrombopoietin	NULL
binding	NULL
to	NULL
its	NULL
receptor	NULL
are	NULL
largely	NULL
unknown	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
,	NULL
in	NULL
BaF3	NULL
cells	NULL
engineered	NULL
to	NULL
express	NULL
murine	NULL
c-Mpl	NULL
,	NULL
thrombopoietin	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
several	NULL
proteins	NULL
,	NULL
including	NULL
c-Mpl	NULL
itself	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Shc	NULL
.	NULL
``	NULL

We	NULL
previously	NULL
reported	NULL
that	NULL
treatment	NULL
of	NULL
human	NULL
platelets	NULL
with	NULL
thrombopoietin	NULL
led	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
several	NULL
intracellular	NULL
proteins	NULL
with	NULL
relative	NULL
molecular	NULL
weights	NULL
of	NULL
130	NULL
,	NULL
95	NULL
,	NULL
85	NULL
,	NULL
and	NULL
52	NULL
kD	NULL
.	NULL
``	NULL

Using	NULL
specific	NULL
antisera	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
Jak2	NULL
and	NULL
Shc	NULL
were	NULL
two	NULL
of	NULL
the	NULL
proteins	NULL
that	NULL
were	NULL
inducibly	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
platelets	NULL
in	NULL
response	NULL
to	NULL
thrombopoietin	NULL
.	NULL
'	NULL

''	NULL
Furthermore	NULL
,	NULL
we	NULL
have	NULL
preliminary	NULL
data	NULL
that	NULL
suggest	NULL
that	NULL
treatment	NULL
of	NULL
platelets	NULL
with	NULL
thrombopoietin	NULL
(	NULL
1	NULL
to	NULL
10	NULL
ng/mL	NULL
)	NULL
enhances	NULL
aggregation	NULL
induced	NULL
by	NULL
various	NULL
agonists	NULL
such	NULL
as	NULL
epinephrine	NULL
and	NULL
ADP	NULL
(	NULL
manuscript	NULL
submitted	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
c-Mpl	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
platelets	NULL
is	NULL
functional	NULL
.	NULL

Thus	NULL
,	NULL
thrombopoietin	NULL
appears	NULL
to	NULL
be	NULL
similar	NULL
to	NULL
other	NULL
cytokines	NULL
such	NULL
as	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
interleu-kin-3	NULL
(	NULL
IL-3	NULL
)	NULL
,	NULL
and	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
)	NULL
,	NULL
which	NULL
are	NULL
not	NULL
only	NULL
required	NULL
for	NULL
the	NULL
proliferation	NULL
and	NULL
maturation	NULL
of	NULL
progenitor	NULL
cells	NULL
but	NULL
stimulate	NULL
the	NULL
functions	NULL
of	NULL
mature	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
new	NULL
class	NULL
of	NULL
transcription	NULL
factors	NULL
termed	NULL
Stat	NULL
(	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
)	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
They	NULL
appear	NULL
to	NULL
have	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
signal	NULL
transduction	NULL
elicited	NULL
by	NULL
cytokines	NULL
,	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
,	NULL
interferons	NULL
,	NULL
growth	NULL
hormone	NULL
,	NULL
prolactin	NULL
,	NULL
or	NULL
epidermal	NULL
growth	NULL
factor	NULL
In	NULL
all	NULL
cases	NULL
,	NULL
the	NULL
Stat	NULL
proteins	NULL
appear	NULL
to	NULL
be	NULL
dormant	NULL
in	NULL
resting	NULL
cells	NULL
.	NULL

On	NULL
stimulation	NULL
of	NULL
cells	NULL
with	NULL
growth	NULL
factor	NULL
or	NULL
cytokine	NULL
,	NULL
they	NULL
become	NULL
tyrosine	NULL
phosphory-lated	NULL
,	NULL
possibly	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
Jak	NULL
family	NULL
tyrosine	NULL
kinase	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
the	NULL
Stat	NULL
pro	NULL
Blood	NULL
,	NULL
Vol	NULL
87	NULL
,	NULL
No	NULL
2	NULL
(	NULL
January	NULL
15	NULL
)	NULL
,	NULL
1996	NULL
:	NULL
pp	NULL
439-446	NULL
response	NULL
to	NULL
thrombopoietin	NULL
.	NULL

We	NULL
immunologically	NULL
identified	NULL
Stat1	NULL
,	NULL
Stat2	NULL
,	NULL
Stat3	NULL
,	NULL
and	NULL
Stat5	NULL
in	NULL
human	NULL
platelet	NULL
lysates	NULL
.	NULL

Thrombopoietin	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
and	NULL
Stat5	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Thrombopoietin	NULL
also	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
and	NULL
Stat5	NULL
in	NULL
FDCP-2	NULL
cells	NULL
genetically	NULL
engineered	NULL
to	NULL
constitutively	NULL
express	NULL
human	NULL
c-Mpl	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
Stat3	NULL
and	NULL
Stat5	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
after	NULL
ligand	NULL
binding	NULL
to	NULL
c-Mp	NULL
!	NULL

and	NULL
that	NULL
this	NULL
event	NULL
may	NULL
have	NULL
a	NULL
role	NULL
in	NULL
megakaryopoiesis/thrombo-poiesis	NULL
or	NULL
possibly	NULL
a	NULL
mature	NULL
platelet	NULL
function	NULL
such	NULL
as	NULL
aggregation	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

tein	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
homo-	NULL
or	NULL
hetero-dimerization	NULL
,	NULL
translocation	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
formation	NULL
of	NULL
DNA	NULL
binding	NULL
complexes	NULL
.	NULL
``	NULL

Given	NULL
the	NULL
presence	NULL
of	NULL
functional	NULL
thrombopoietin	NULL
receptors	NULL
on	NULL
platelets	NULL
and	NULL
our	NULL
previous	NULL
observation	NULL
of	NULL
Jak2	NULL
activation	NULL
after	NULL
stimulation	NULL
with	NULL
thrombopoietin	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
possibility	NULL
that	NULL
platelets	NULL
may	NULL
have	NULL
Stat	NULL
proteins	NULL
and	NULL
,	NULL
if	NULL
so	NULL
,	NULL
whether	NULL
they	NULL
become	NULL
tyrosine	NULL
phosphorylated	NULL
after	NULL
treatment	NULL
with	NULL
thrombopoietin	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
whether	NULL
Jak2	NULL
activation	NULL
and	NULL
Stat	NULL
phosphorylation	NULL
correlated	NULL
with	NULL
parameters	NULL
of	NULL
platelet	NULL
function	NULL
,	NULL
eg	NULL
,	NULL
aggregation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Materials	NULL
.	NULL

-	NULL
Prostaglandin	NULL
E	NULL
,	NULL
(	NULL
PGE	NULL
;	NULL
,	NULL
)	NULL
,	NULL
epinephrine	NULL
,	NULL
aspirin	NULL
,	NULL
apyrase	NULL
(	NULL
type	NULL
VIH	NULL
)	NULL
,	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
)	NULL
,	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
2-mercaptoethanol	NULL
,	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
chicken	NULL
egg	NULL
albumin	NULL
,	NULL
protein	NULL
A-Sepharose	NULL
,	NULL
antimouse	NULL
IgG-conjugated	NULL
agarose	NULL
,	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
Tris	NULL
(	NULL
hydro-xymethyl	NULL
)	NULL
aminomethane	NULL
(	NULL
Tris	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Polyvinylidene	NULL
difluoride	NULL
(	NULL
PVDF	NULL
)	NULL
membrane	NULL
(	NULL
pore	NULL
size	NULL
,	NULL
0.45	NULL
mm	NULL
)	NULL
was	NULL
from	NULL
Millipore	NULL
Corp	NULL
(	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
molecular	NULL
standards	NULL
were	NULL
from	NULL
Amersham	NULL
(	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Enhanced	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Hematology	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
and	NULL
the	NULL
Blood	NULL
Center	NULL
,	NULL
Keio	NULL
University	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
;	NULL
the	NULL
Division	NULL
of	NULL
Hematology	NULL
and	NULL
Medical	NULL
Oncology	NULL
,	NULL
Oregon	NULL
Health	NULL
Sciences	NULL
University	NULL
,	NULL
Portland	NULL
,	NULL
OR	NULL
;	NULL
and	NULL
the	NULL
Pharmaceutical	NULL
Research	NULL
Laboratory	NULL
,	NULL
Kirin	NULL
Brewery	NULL
Co	NULL
,	NULL
Ltd	NULL
,	NULL
Maebashi	NULL
,	NULL
Japan	NULL
.	NULL

Submitted	NULL
June	NULL
30	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
October	NULL
13	NULL
,	NULL
1995	NULL
,	NULL
Y.M	NULL
.	NULL

and	NULL
A.O	NULL
.	NULL

equally	NULL
contributed	NULL
to	NULL
this	NULL
work	NULL
and	NULL
should	NULL
be	NULL
regarded	NULL
as	NULL
co-first	NULL
authors	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
Grants	NULL
in	NULL
Aid	NULL
from	NULL
The	NULL
Ministry	NULL
of	NULL
Educa-tion	NULL
,	NULL
Science	NULL
and	NULL
Technology	NULL
of	NULL
Japan	NULL
(	NULL
Y..	NULL
and	NULL
A.O	NULL
.	NULL
)	NULL

and	NULL
The	NULL
Ryoichi	NULL
Naito	NULL
Foundation	NULL
for	NULL
Medical	NULL
Research	NULL
(	NULL
A.0	NULL
.	NULL
)	NULL

.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Yasuo	NULL
Ikeda	NULL
,	NULL
MD	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Keio	NULL
University	NULL
,	NULL
35	NULL
Shinano-machi	NULL
,	NULL
Shinjuku-ku	NULL
,	NULL
Tokyo	NULL
160	NULL
,	NULL
Japan	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/96/8702-0051	NULL
$	NULL
3.00/0	NULL
439	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

440	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
reagents	NULL
,	NULL
including	NULL
second	NULL
antibodies	NULL
,	NULL
were	NULL
purchased	NULL
from	NULL
Amersham	NULL
.	NULL

Antiphosphotyrosine	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
4G10	NULL
)	NULL
was	NULL
used	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Anti-Jak2	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
were	NULL
from	NULL
UBI	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Specific	NULL
anti-Statl	NULL
,	NULL
-Stat2	NULL
,	NULL
-Stat5	NULL
,	NULL
and	NULL
-Stat6	NULL
antibodies	NULL
and	NULL
Rous	NULL
sarcoma	NULL
virus-transformed	NULL
(	NULL
RSV	NULL
)	NULL
-NIH-3T3	NULL
cell	NULL
lysates	NULL
,	NULL
a	NULL
positive	NULL
con	NULL
A	NULL
1	NULL
200300	NULL
4	NULL
5	NULL
6	NULL
(	NULL
Mug	NULL
)	NULL
Stat3	NULL
-	NULL
>	NULL
»	NULL
--	NULL
e	NULL
»	NULL
amp	NULL
aam	NULL
w=	NULL
97.4	NULL
«	NULL
-*	NULL
GG	NULL
IP	NULL
:	NULL
anti-Stat3	NULL
WB	NULL
:	NULL
anti-PY	NULL
M.W	NULL
.	NULL

B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
(	NULL
kDa	NULL
)	NULL
Stitt	NULL
-	NULL
>	NULL
<	NULL
P	NULL
dap	NULL
co	NULL
dp	NULL
a	NULL
»	NULL
ce	NULL
»	NULL
~~	NULL
*+	NULL
==	NULL
69	NULL
IP	NULL
:	NULL
anti-Stat3	NULL
WB	NULL
:	NULL
anti-Stat3	NULL
M.W	NULL
.	NULL

1	NULL
3	NULL
(	NULL
kDa	NULL
)	NULL
C	NULL
ale	NULL
~	NULL
--	NULL
=	NULL
200	NULL
Stat3	NULL
-	NULL
>	NULL
»	NULL
97.4	NULL
WB	NULL
:	NULL
anti-Stat3	NULL
Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
in	NULL
platelets	NULL
stimulated	NULL
by	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

Platelets	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
before	NULL
and	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

Stat3	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
anti-Stat3	NULL
antisera	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
lysed	NULL
with	NULL
SDS-sample	NULL
buffer	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
onto	NULL
PVDF	NULL
membranes	NULL
.	NULL

Immunoblots	NULL
were	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
and	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
platelets	NULL
.	NULL

Lanes	NULL
2	NULL
through	NULL
6	NULL
,	NULL
15	NULL
seconds	NULL
,	NULL
1	NULL
minute	NULL
,	NULL
5	NULL
minutes	NULL
,	NULL
10	NULL
minutes	NULL
,	NULL
and	NULL
30	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
same	NULL
PVDF	NULL
membrane	NULL
used	NULL
in	NULL
(	NULL
A	NULL
)	NULL
was	NULL
stripped	NULL
of	NULL
the	NULL
antibody	NULL
and	NULL
reprobed	NULL
for	NULL
Stat3	NULL
.	NULL

Bands	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
.	NULL

Lanes	NULL
are	NULL
the	NULL
same	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Anti-Stat3	NULL
recognized	NULL
the	NULL
same	NULL
protein	NULL
in	NULL
lysates	NULL
from	NULL
platelets	NULL
and	NULL
RSV-3T3	NULL
cells	NULL
.	NULL

Platelets	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
2x	NULL
SDS-sample	NULL
buffer	NULL
.	NULL

After	NULL
boiling	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
onto	NULL
PVDF	NULL
membranes	NULL
.	NULL

Stat3	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
specific	NULL
antibody	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
platelets	NULL
(	NULL
1.5	NULL
x	NULL
10°	NULL
cells/lane	NULL
}	NULL
.	NULL

Lane	NULL
2	NULL
,	NULL
RSV-3T3	NULL
cells	NULL
(	NULL
20	NULL
ug	NULL
protein/lane	NULL
}	NULL
.	NULL

MIYAKAWA	NULL
ET	NULL
AL	NULL
M.	NULL
W.	NULL
1	NULL
2	NULL
3	NULL
4	NULL
-	NULL
5	NULL
(	NULL
kDa	NULL
)	NULL
A	NULL
m.	NULL
200	NULL
_	NULL
974	NULL
~*	NULL
69	NULL
*~	NULL
46	NULL
IP	NULL
:	NULL
Anti-PY	NULL
(	NULL
4G10	NULL
)	NULL
WB	NULL
:	NULL
Anti-Stat5	NULL
M.W	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
(	NULL
kDa	NULL
)	NULL
B	NULL
=	NULL
--	NULL
200	NULL
Tak2	NULL
-	NULL
»	NULL
oo	NULL
as	NULL
ar	NULL
aw	NULL
j	NULL
=	NULL
--	NULL
97.4	NULL
IP	NULL
:	NULL
anti-PY	NULL
WB	NULL
:	NULL
anti-Jak2	NULL
M.w	NULL
.	NULL

C	NULL
1	NULL
2	NULL
(	NULL
kDa	NULL
)	NULL
--	NULL
200	NULL
Stats	NULL
-	NULL
>	NULL
»	NULL
.——	NULL
~-	NULL
_	NULL
974	NULL
--	NULL
69	NULL
WB	NULL
:	NULL
anti-Stat5	NULL
Fig	NULL
2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Protein	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat5	NULL
in	NULL
platelets	NULL
stimulated	NULL
by	NULL
thrombopoietin	NULL
(	NULL
TPO	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

Platelets	NULL
were	NULL
lysed	NULL
in	NULL
SDS	NULL
and	NULL
lysates	NULL
were	NULL
diluted	NULL
10-fold	NULL
.	NULL

Tyrosine	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
4G10	NULL
.	NULL

After	NULL
boiling	NULL
for	NULL
5	NULL
minutes	NULL
in	NULL
SDS-sample	NULL
buffer	NULL
,	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
onto	NULL
PVDF	NULL
membranes	NULL
.	NULL

Stat5	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
specific	NULL
antibody	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
platelets	NULL
.	NULL

Lanes	NULL
2	NULL
through	NULL
5	NULL
,	NULL
15	NULL
seconds	NULL
,	NULL
1	NULL
minute	NULL
,	NULL
5	NULL
minutes	NULL
,	NULL
and	NULL
10	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

HC	NULL
,	NULL
heavy	NULL
chain	NULL
of	NULL
IgG	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Protein	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
in	NULL
platelets	NULL
stimulated	NULL
by	NULL
thrombopoietin	NULL
(	NULL
TPO	NULL
100	NULL
ng/	NULL
mL	NULL
)	NULL
.	NULL

Platelets	NULL
were	NULL
lysed	NULL
as	NULL
in	NULL
Fig	NULL
1	NULL
.	NULL

Tyrosine	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
4G10	NULL
.	NULL

After	NULL
boiling	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
onto	NULL
PVDF	NULL
membranes	NULL
.	NULL

Jak2	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
specific	NULL
antibody	NULL
.	NULL

Lanes	NULL
are	NULL
the	NULL
same	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Anti-Stat5	NULL
recognized	NULL
the	NULL
same	NULL
protein	NULL
in	NULL
lysates	NULL
from	NULL
platelets	NULL
and	NULL
RSV-3T3	NULL
cells	NULL
.	NULL

The	NULL
same	NULL
as	NULL
Fig	NULL
1C	NULL
except	NULL
that	NULL
Stat5	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
specific	NULL
antibody	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
platelets	NULL
(	NULL
1.5	NULL
x	NULL
10	NULL
'	NULL
cells/lane	NULL
)	NULL
.	NULL

Lane	NULL
2	NULL
,	NULL
RSV-3T3	NULL
cells	NULL
(	NULL
20	NULL
ug	NULL
protein/lane	NULL
}	NULL
.	NULL

trol	NULL
for	NULL
the	NULL
transcription	NULL
factors	NULL
,	NULL
were	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

Anti-Stat3	NULL
,	NULL
anti-Stat4	NULL
,	NULL
and	NULL
anti-Tyk2	NULL
were	NULL
from	NULL
Santa	NULL
Cruz	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Iscove	NULL
's	NULL
modified	NULL
Dul-beco	NULL
's	NULL
medium	NULL
(	NULL
IMDM	NULL
)	NULL
was	NULL
from	NULL
GIBCO	NULL
BRL	NULL
(	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Recombinant	NULL
hirudin	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Japan	NULL
Energy	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

PLATELETS	NULL
AND	NULL
STAT	NULL
PROTEINS	NULL
441	NULL
M.W	NULL
.	NULL

M.W	NULL
.	NULL

A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
(	NULL
kDa	NULL
)	NULL
D	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
(	NULL
kDa	NULL
)	NULL
Stat3	NULL
-	NULL
>	NULL
»	NULL
h	NULL
\	NULL
m4	NULL
aX	NULL
--	NULL
974	NULL
_	NULL
Stats	NULL
-	NULL
>	NULL
»	NULL
i	NULL
|	NULL
®	NULL
--	NULL
-	NULL
97.4	NULL
o_	NULL
.	NULL

i	NULL
Pro	NULL
a	NULL
_	NULL
;	NULL
,	NULL
IP	NULL
:	NULL
anti-Stat3	NULL
IP	NULL
anti-FY	NULL
WB	NULL
:	NULL
anti-PY	NULL
WB	NULL
:	NULL
anti-Stat5	NULL
M.W	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
(	NULL
kDa	NULL
)	NULL
M.W	NULL
.	NULL

B	NULL
1	NULL
2	NULL
3	NULL
0	NULL
4	NULL
5006	NULL
(	NULL
kDa	NULL
)	NULL
Stat3	NULL
-	NULL
>	NULL
»	NULL
--	NULL
944	NULL
--	NULL
200	NULL
m-	NULL
'	NULL
69	NULL
Jak2	NULL
-	NULL
>	NULL
»	NULL
-	NULL
Wit	NULL
-	NULL
irate	NULL
w=	NULL
97.4	NULL
IP	NULL
:	NULL
anti-Stat3	NULL
_	NULL
WB	NULL
:	NULL
anti-Stat3	NULL
IP	NULL
:	NULL
anti-PY	NULL
WB	NULL
:	NULL
anti-Jak2	NULL
M.W	NULL
.	NULL

(	NULL
kDa	NULL
)	NULL
IP	NULL
:	NULL
anti-Jak2	NULL
WB	NULL
:	NULL
anti-PY	NULL
Fig	NULL
3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
in	NULL
FDCP-hMPLS	NULL
cells	NULL
stimulated	NULL
by	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

FDCP-hMPLS	NULL
cells	NULL
(	NULL
10	NULL
'	NULL
cells/	NULL
mL	NULL
in	NULL
PBS	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
before	NULL
and	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

Stat3	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
anti-Stat3	NULL
antisera	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
lysed	NULL
with	NULL
SDS-sample	NULL
buffer	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
was	NULL
detected	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
1A	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
cells	NULL
.	NULL

Lanes	NULL
2	NULL
through	NULL
6	NULL
,	NULL
1	NULL
minute	NULL
,	NULL
5	NULL
minutes	NULL
,	NULL
10	NULL
minutes	NULL
,	NULL
30	NULL
minutes	NULL
,	NULL
and	NULL
60	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
same	NULL
PVDF	NULL
membrane	NULL
used	NULL
in	NULL
(	NULL
A	NULL
)	NULL
was	NULL
stripped	NULL
of	NULL
the	NULL
antibody	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Stat3	NULL
antisera	NULL
.	NULL

Bands	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
.	NULL

Lanes	NULL
are	NULL
the	NULL
same	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
in	NULL
FDCP-hMPLS5	NULL
cells	NULL
stimulated	NULL
by	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

FDCP-hMPLS5	NULL
cells	NULL
(	NULL
10	NULL
'	NULL
cells/mL	NULL
in	NULL
PBS	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
before	NULL
and	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

Jak2	NULL
was	NULL
immunoprecipitated	NULL
and	NULL
its	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
detected	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
1A	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
cells	NULL
.	NULL

Lanes	NULL
2	NULL
through	NULL
6	NULL
,	NULL
1	NULL
minute	NULL
,	NULL
5	NULL
minutes	NULL
,	NULL
10	NULL
minutes	NULL
,	NULL
30	NULL
minutes	NULL
,	NULL
and	NULL
60	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

The	NULL
same	NULL
lysates	NULL
as	NULL
used	NULL
in	NULL
(	NULL
A	NULL
)	NULL
and	NULL
(	NULL
B	NULL
)	NULL
were	NULL
used	NULL
.	NULL

Lanes	NULL
are	NULL
the	NULL
same	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat5	NULL
in	NULL
FDCP-hMPLS	NULL
cells	NULL
stimulated	NULL
by	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
4G10	NULL
.	NULL

After	NULL
boiling	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
onto	NULL
PVDF	NULL
membranes	NULL
.	NULL

Stat5	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
specific	NULL
antibody	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
cells	NULL
.	NULL

Lanes	NULL
2	NULL
through	NULL
6	NULL
,	NULL
1	NULL
minute	NULL
,	NULL
5	NULL
minutes	NULL
,	NULL
10	NULL
minutes	NULL
,	NULL
30	NULL
minutes	NULL
,	NULL
and	NULL
60	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

(	NULL
E	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
in	NULL
FDCP-hMPLS	NULL
cells	NULL
stimulated	NULL
by	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

The	NULL
same	NULL
lysates	NULL
as	NULL
used	NULL
in	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Jak2	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
specific	NULL
antibody	NULL
.	NULL

Lanes	NULL
are	NULL
the	NULL
same	NULL
as	NULL
in	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Co	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Human	NULL
erythropoietin	NULL
was	NULL
from	NULL
Kirin	NULL
Brewery	NULL
Co	NULL
,	NULL
Ltd	NULL
(	NULL
Maebashi	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Recombinant	NULL
thrombopoietin	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
.	NULL

``	NULL
®	NULL
An	NULL
expression	NULL
plasmid	NULL
containing	NULL
the	NULL
full-length	NULL
human	NULL
c-mpl	NULL
cDNA	NULL
driven	NULL
by	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
Moloney	NULL
murine	NULL
sarcoma	NULL
virus	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Amgen	NULL
Inc	NULL
(	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

!	NULL

Platelet	NULL
preparation	NULL
.	NULL

-	NULL
Human	NULL
blood	NULL
from	NULL
healthy	NULL
volunteers	NULL
was	NULL
drawn	NULL
by	NULL
venipuncture	NULL
into	NULL
1/10	NULL
volume	NULL
of	NULL
3.8	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
trisodium	NULL
citrate	NULL
and	NULL
gently	NULL
mixed	NULL
.	NULL

Platelet-rich	NULL
plasma	NULL
(	NULL
PRP	NULL
)	NULL
was	NULL
prepared	NULL
by	NULL
centrifuging	NULL
the	NULL
whole	NULL
blood	NULL
at	NULL
200g	NULL
for	NULL
20	NULL
minutes	NULL
and	NULL
aspirating	NULL
PRP	NULL
.	NULL

PRP	NULL
was	NULL
incubated	NULL
with	NULL
aspirin	NULL
(	NULL
2	NULL
mmol/L	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

PGE	NULL
,	NULL
(	NULL
1	NULL
pmol/L	NULL
)	NULL
was	NULL
added	NULL
from	NULL
a	NULL
stock	NULL
solution	NULL
in	NULL
absolute	NULL
ethanol	NULL
(	NULL
1	NULL
mmol/L	NULL
)	NULL
.	NULL

The	NULL
PRP	NULL
was	NULL
spun	NULL
at	NULL
800g	NULL
to	NULL
form	NULL
a	NULL
soft	NULL
platelet	NULL
pellet	NULL
.	NULL

The	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
1	NULL
mL	NULL
of	NULL
a	NULL
modified	NULL
HEPES-Tyrode	NULL
buffer	NULL
(	NULL
129	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
8.9	NULL
mmol/	NULL
L	NULL
NaHCO	NULL
;	NULL
,	NULL
0.8	NULL
mmol/L	NULL
KH	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
0.8	NULL
mmol/L	NULL
MgClI	NULL
;	NULL
,	NULL
5.6	NULL
mmol/L	NULL
dextrose	NULL
,	NULL
and	NULL
10	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
also	NULL
containing	NULL
apyrase	NULL
(	NULL
2	NULL
U/mL	NULL
)	NULL
and	NULL
washed	NULL
twice	NULL
.	NULL

Platelets	NULL
were	NULL
resuspended	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
3	NULL
X	NULL
10°	NULL
cells/mL	NULL
with	NULL
apyrase	NULL
(	NULL
2	NULL
U/	NULL
mL	NULL
)	NULL
containing	NULL
1	NULL
mmol/L	NULL
CaCl	NULL
;	NULL
at	NULL
37°C	NULL
.	NULL

To	NULL
make	NULL
hirudin	NULL
PRP	NULL
,	NULL
hirudin	NULL
(	NULL
final	NULL
concentration	NULL
,	NULL
100	NULL
U/mL	NULL
)	NULL
was	NULL
mixed	NULL
with	NULL
whole	NULL
blood	NULL
instead	NULL
of	NULL
citrate	NULL
.	NULL

Cell	NULL
lines	NULL
.	NULL

-	NULL
Murine	NULL
IL-3-dependent	NULL
myeloid	NULL
cell	NULL
line	NULL
FDCP-2*	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
Arinobu	NULL
Tojo	NULL
,	NULL
Institute	NULL
of	NULL
Medical	NULL
Science	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
was	NULL
maintained	NULL
in	NULL
IMDM	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
and	NULL
1	NULL
ng/mL	NULL
murine	NULL
IL-3	NULL
.	NULL

A	NULL
thrombopoietin-dependent	NULL
cell	NULL
line	NULL
(	NULL
FDCP-hMPL35	NULL
)	NULL
was	NULL
established	NULL
by	NULL
transforming	NULL
FDCP-2	NULL
cells	NULL
with	NULL
an	NULL
expression	NULL
plasmid	NULL
containing	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

442	NULL
m.w	NULL
.	NULL

A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
(	NULL
kDa	NULL
)	NULL
Stat3	NULL
-	NULL
>	NULL
»	NULL
eme	NULL
.	NULL

-	NULL
``	NULL
~	NULL
97.4	NULL
IP	NULL
:	NULL
anti-Stat3	NULL
WB	NULL
:	NULL
anti-PY	NULL
M.W	NULL
.	NULL

B	NULL
1	NULL
2	NULL
(	NULL
kDa	NULL
)	NULL
Stats	NULL
-	NULL
>	NULL
»	NULL
wl	NULL
)	NULL
-	NULL
*+	NULL
sue	NULL
:	NULL
§9	NULL
IP	NULL
:	NULL
anti-PY	NULL
WB	NULL
:	NULL
anti-Stat5	NULL
Fig	NULL
4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
in	NULL
FDCP-hMPLS	NULL
cells	NULL
stimulated	NULL
by	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
but	NULL
not	NULL
in	NULL
FD-ER3	NULL
cells	NULL
treated	NULL
with	NULL
erythropoietin	NULL
(	NULL
15	NULL
U/mL	NULL
)	NULL
.	NULL

FD-ER3	NULL
or	NULL
FDCP-hMPLS5	NULL
cells	NULL
(	NULL
10	NULL
'	NULL
cells/mL	NULL
in	NULL
PBS	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
before	NULL
and	NULL
after	NULL
exposure	NULL
to	NULL
erythropoietin	NULL
(	NULL
15	NULL
U/mL	NULL
)	NULL
or	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

Stat3	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
anti-Stat3	NULL
antisera	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
lysed	NULL
with	NULL
SDS-sample	NULL
buffer	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
was	NULL
detected	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
1A	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
FD-ER3	NULL
cells	NULL
.	NULL

Lane	NULL
2	NULL
,	NULL
10	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
erythropoietin	NULL
(	NULL
15	NULL
U/mL	NULL
;	NULL
FD-ER3	NULL
cells	NULL
)	NULL
.	NULL

Lane	NULL
3	NULL
,	NULL
resting	NULL
FDCP-hMPLS	NULL
cells	NULL
.	NULL

Lane	NULL
4	NULL
,	NULL
10	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
;	NULL
FDCP-hMPL5	NULL
)	NULL
.	NULL

The	NULL
same	NULL
PVDF	NULL
membrane	NULL
was	NULL
stripped	NULL
of	NULL
the	NULL
antibody	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Stat3	NULL
antisera	NULL
and	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
Stat3	NULL
was	NULL
detected	NULL
in	NULL
each	NULL
lane	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat5	NULL
in	NULL
FD-ER3	NULL
stimulated	NULL
by	NULL
erythropoietin	NULL
(	NULL
15	NULL
U/mL	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
4G10	NULL
.	NULL

After	NULL
boiling	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
onto	NULL
PVDF	NULL
membranes	NULL
.	NULL

Stat5	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
specific	NULL
antibody	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
cells	NULL
.	NULL

Lane	NULL
2	NULL
,	NULL
10	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
erythropoietin	NULL
(	NULL
15	NULL
U/mL	NULL
)	NULL
.	NULL

the	NULL
full-length	NULL
human	NULL
c-mpl	NULL
cDNA	NULL
driven	NULL
by	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
Moloney	NULL
murine	NULL
sarcoma	NULL
virus	NULL
.	NULL

*	NULL
``	NULL
This	NULL
cell	NULL
line	NULL
expresses	NULL
human	NULL
c-Mpl	NULL
protein	NULL
on	NULL
its	NULL
cell	NULL
surface	NULL
and	NULL
can	NULL
grow	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
recombinant	NULL
thrombopoietin	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

FDCP-2	NULL
cells	NULL
expressing	NULL
murine	NULL
erythropoietin	NULL
receptors	NULL
(	NULL
FD-ER3	NULL
cells	NULL
)	NULL
were	NULL
established	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

Before	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
thrombopoietin	NULL
or	NULL
erythropoietin	NULL
,	NULL
they	NULL
were	NULL
incubated	NULL
in	NULL
IMDM	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
without	NULL
exogenous	NULL
IL-3	NULL
for	NULL
6	NULL
hours	NULL
.	NULL

After	NULL
two	NULL
washes	NULL
,	NULL
they	NULL
were	NULL
incubated	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
;	NULL
pH	NULL
7.4	NULL
)	NULL
.	NULL

Gel	NULL
electrophoresis	NULL
and	NULL
Western	NULL
blotting	NULL
to	NULL
detect	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
or	NULL
Stat	NULL
proteins	NULL
.	NULL

-	NULL
Platelet	NULL
stimulation	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
2	NULL
%	NULL
concentrated	NULL
Laemmli	NULL
's	NULL
sample	NULL
buffer	NULL
(	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
5	NULL
%	NULL
2-mercaptoethanol	NULL
,	NULL
50	NULL
mmol/L	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
6.8	NULL
]	NULL
,	NULL
and	NULL
0.002	NULL
%	NULL
bromophenol	NULL
blue	NULL
)	NULL
,	NULL
``	NULL
10	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
and	NULL
1	NULL
mmol/L	NULL
sodium	NULL
orthovanadate	NULL
.	NULL

After	NULL
boiling	NULL
at	NULL
95°C	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
one-dimensional	NULL
SDS-electro-phoresis	NULL
was	NULL
performed	NULL
on	NULL
10	NULL
%	NULL
or	NULL
12	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Separated	NULL
proteins	NULL
were	NULL
electrophoretically	NULL
transferred	NULL
from	NULL
the	NULL
gel	NULL
onto	NULL
PVDF	NULL
membranes	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
Tris	NULL
(	NULL
25	NULL
mmol/L	NULL
)	NULL
,	NULL
glycine	NULL
(	NULL
192	NULL
mmol/L	NULL
)	NULL
,	NULL
and	NULL
20	NULL
%	NULL
methanol	NULL
at	NULL
0.2	NULL
amps	NULL
for	NULL
12	NULL
hours	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

To	NULL
block	NULL
residual	NULL
protein	NULL
binding	NULL
MIYAKAWA	NULL
ET	NULL
AL	NULL
sites	NULL
,	NULL
transfer	NULL
membranes	NULL
were	NULL
incubated	NULL
in	NULL
TBST	NULL
(	NULL
Tris-buffered	NULL
saline	NULL
[	NULL
TBS	NULL
]	NULL
,	NULL
10	NULL
mmol/L	NULL
Tris	NULL
,	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
with	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
with	NULL
10	NULL
%	NULL
chicken	NULL
egg	NULL
albumin	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
washed	NULL
with	NULL
TBST	NULL
and	NULL
incubated	NULL
overnight	NULL
with	NULL
primary	NULL
antibodies	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1.0	NULL
pg/mL	NULL
in	NULL
TBST	NULL
.	NULL

The	NULL
primary	NULL
antibody	NULL
was	NULL
removed	NULL
and	NULL
the	NULL
blots	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
in	NULL
TBST	NULL
and	NULL
incubated	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
second	NULL
antibody	NULL
diluted	NULL
1:3,000	NULL
in	NULL
TBST	NULL
.	NULL

Blots	NULL
were	NULL
then	NULL
washed	NULL
four	NULL
times	NULL
in	NULL
TBST	NULL
.	NULL

Antibody	NULL
reactions	NULL
were	NULL
detected	NULL
with	NULL
chemiluminescence	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Immunoprecipitation	NULL
.	NULL

_	NULL
Cell	NULL
stimulation	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
15	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
PMSF	NULL
,	NULL
10	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
1	NULL
mmol/L	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
0.8	NULL
mg/mL	NULL
leupeptin	NULL
,	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
[	NULL
vol/	NULL
wt	NULL
}	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
.	NULL

After	NULL
20	NULL
minutes	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
lysates	NULL
were	NULL
centrifuged	NULL
at	NULL
10,0008	NULL
(	NULL
at	NULL
4°C	NULL
)	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
removed	NULL
and	NULL
incubated	NULL
with	NULL
preimmune	NULL
serum	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
40	NULL
uL	NULL
of	NULL
50	NULL
%	NULL
slurry	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
.	NULL

The	NULL
desired	NULL
polyclonal	NULL
or	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
then	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
2	NULL
to	NULL
3	NULL
hours	NULL
on	NULL
ice	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
or	NULL
antimouse	NULL
IgG-conjugated	NULL
agarose	NULL
(	NULL
40	NULL
LL	NULL
of	NULL
50	NULL
%	NULL
slurry	NULL
)	NULL
was	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
several	NULL
hours	NULL
.	NULL

The	NULL
immune	NULL
complexes	NULL
were	NULL
washed	NULL
with	NULL
1	NULL
mL	NULL
of	NULL
cold	NULL
washing	NULL
buffer	NULL
(	NULL
15	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
PMSF	NULL
,	NULL
10	NULL
mmol/	NULL
L	NULL
EGTA	NULL
,	NULL
1	NULL
mmol/L	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
0.8	NULL
mg/mL	NULL
leupeptin	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
[	NULL
vol/wt	NULL
]	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
three	NULL
times	NULL
and	NULL
then	NULL
lysed	NULL
with	NULL
Laemmli	NULL
's	NULL
sample	NULL
buffer	NULL
.	NULL

When	NULL
immunoprecipitation	NULL
of	NULL
denatured	NULL
proteins	NULL
was	NULL
necessary	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
first	NULL
in	NULL
1	NULL
%	NULL
SDS	NULL
and	NULL
boiled	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
diluted	NULL
10-fold	NULL
in	NULL
the	NULL
lysis	NULL
buffer	NULL
that	NULL
contains	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
before	NULL
immunoprecipitation	NULL
.	NULL

Measurement	NULL
of	NULL
platelet	NULL
aggregation	NULL
.	NULL

The	NULL
measurement	NULL
of	NULL
platelet	NULL
aggregation	NULL
was	NULL
performed	NULL
with	NULL
an	NULL
aggregometer	NULL
(	NULL
Hema	NULL
Tracer	NULL
TM	NULL
Model	NULL
601	NULL
;	NULL
Niko	NULL
Bio	NULL
Science	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
with	NULL
continuous	NULL
stirring	NULL
(	NULL
1,000	NULL
rpm	NULL
)	NULL
.	NULL

RESULTS	NULL
In	NULL
preliminary	NULL
experiments	NULL
,	NULL
we	NULL
found	NULL
that	NULL
human	NULL
platelets	NULL
express	NULL
Statl	NULL
,	NULL
Stat2	NULL
,	NULL
Stat3	NULL
,	NULL
and	NULL
Stat5	NULL
but	NULL
not	NULL
Stat4	NULL
or	NULL
Stat6	NULL
by	NULL
immunoblotting	NULL
with	NULL
specific	NULL
antisera	NULL
.	NULL

A	NULL
positive	NULL
control	NULL
cell	NULL
lysate	NULL
(	NULL
RSV-3T3	NULL
)	NULL
was	NULL
used	NULL
to	NULL
confirm	NULL
that	NULL
the	NULL
Stat	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
specific	NULL
antisera	NULL
and	NULL
that	NULL
the	NULL
proteins	NULL
detected	NULL
in	NULL
platelets	NULL
comigrated	NULL
with	NULL
the	NULL
Stat	NULL
proteins	NULL
in	NULL
the	NULL
control	NULL
lysates	NULL
(	NULL
Figs	NULL
1C	NULL
and	NULL
2C	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
whether	NULL
any	NULL
of	NULL
the	NULL
Stat	NULL
proteins	NULL
became	NULL
tyrosine	NULL
phosphorylated	NULL
after	NULL
treatment	NULL
of	NULL
platelets	NULL
with	NULL
thrombopoietin	NULL
.	NULL

Platelets	NULL
treated	NULL
with	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
for	NULL
various	NULL
times	NULL
were	NULL
lysed	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
Stat3	NULL
antisera	NULL
.	NULL

The	NULL
same	NULL
amount	NULL
of	NULL
a	NULL
95-kD	NULL
protein	NULL
recognized	NULL
by	NULL
Stat3	NULL
antisera	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
all	NULL
cellular	NULL
lysates	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
thrombopoietin	NULL
,	NULL
this	NULL
same	NULL
protein	NULL
was	NULL
tyrosine	NULL
phosphorylated	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
platelets	NULL
have	NULL
Stat3	NULL
and	NULL
it	NULL
becomes	NULL
tyrosine	NULL
phosphorylated	NULL
after	NULL
thrombopoietin	NULL
treatment	NULL
.	NULL

Similar	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
examine	NULL
whether	NULL
Stat5	NULL
was	NULL
inducibly	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
platelets	NULL
.	NULL

Because	NULL
the	NULL
anti-Stat5	NULL
antibody	NULL
used	NULL
does	NULL
not	NULL
work	NULL
for	NULL
immu-noprecipitations	NULL
,	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
im-munoprecipitated	NULL
,	NULL
from	NULL
denatured	NULL
cellular	NULL
lysates	NULL
,	NULL
with	NULL
a	NULL
specific	NULL
antiphosphotyrosine	NULL
antibody	NULL
(	NULL
4G10	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
,	NULL
in	NULL
the	NULL
antiphosphotyrosine	NULL
immunoprecipitates	NULL
,	NULL
increased	NULL
amounts	NULL
of	NULL
a	NULL
95-kD	NULL
protein	NULL
were	NULL
recognized	NULL
by	NULL
an	NULL
anti-Stat5	NULL
antibody	NULL
after	NULL
stimulation	NULL
of	NULL
platelets	NULL
with	NULL
throm-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

PLATELETS	NULL
AND	NULL
STAT	NULL
PROTEINS	NULL
J	NULL
Fig	NULL
5	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Thrombopoietin	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
in	NULL
platelets	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
.	NULL

Platelets	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
before	NULL
and	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
0.1	NULL
to	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
was	NULL
%	NULL
Aggregation	NULL
10	NULL
%	NULL
443	NULL
IP	NULL
:	NULL
Anti-Stat3	NULL
WB	NULL
:	NULL
Anti-PY	NULL
detected	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
1A	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
priming	NULL
of	NULL
epinephrine-induced	NULL
platelet	NULL
aggregation	NULL
in	NULL
hirudin-PRP	NULL
.	NULL

Aspirin-pretreated	NULL
hirudin-PRP	NULL
was	NULL
incubated	NULL
with	NULL
thrombopoietin	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

Epinephrine	NULL
(	NULL
1	NULL
pmol/L	NULL
)	NULL
was	NULL
then	NULL
added	NULL
(	NULL
the	NULL
upper	NULL
line	NULL
}	NULL
.	NULL

In	NULL
the	NULL
lower	NULL
line	NULL
,	NULL
thrombopoietin	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
was	NULL
added	NULL
after	NULL
stimulation	NULL
with	NULL
epinephrine	NULL
(	NULL
1	NULL
pmol/L	NULL
)	NULL
for	NULL
1	NULL
minute	NULL
.	NULL

Aggregation	NULL
was	NULL
measured	NULL
turbimetri-cally	NULL
.	NULL

93	NULL
g	NULL
O	NULL
bopoietin	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
Statl	NULL
and	NULL
Stat2	NULL
were	NULL
tyrosine	NULL
phosphorylated	NULL
and	NULL
we	NULL
could	NULL
find	NULL
no	NULL
evidence	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
either	NULL
protein	NULL
before	NULL
or	NULL
after	NULL
stimulation	NULL
of	NULL
platelets	NULL
with	NULL
thrombopoietin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Jak2	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
phosphorylate	NULL
Stat5	NULL
on	NULL
tyrosine	NULL
in	NULL
vitro	NULL
and	NULL
possibly	NULL
in	NULL
vivo	NULL
.	NULL
'	NULL

''	NULL
'**	NULL
``	NULL
Consistent	NULL
with	NULL
our	NULL
previous	NULL
observations	NULL
,	NULL
increased	NULL
amounts	NULL
of	NULL
Jak2	NULL
were	NULL
detected	NULL
in	NULL
antiphosphotyrosine	NULL
immunoprecipitates	NULL
after	NULL
stimulation	NULL
of	NULL
platelets	NULL
with	NULL
thrombopoietin	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
occurred	NULL
over	NULL
a	NULL
similar	NULL
time	NULL
course	NULL
to	NULL
that	NULL
of	NULL
Stat3	NULL
and	NULL
Stats	NULL
(	NULL
compare	NULL
Fig	NULL
1A	NULL
and	NULL
Fig	NULL
2A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
the	NULL
link	NULL
between	NULL
thrombopoietin	NULL
stimulation	NULL
and	NULL
Stat3/Stat5	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
Stat3	NULL
and	NULL
Stat5	NULL
were	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
FDCP-2	NULL
cells	NULL
expressing	NULL
human	NULL
c-Mpl	NULL
(	NULL
FDCP-hMPL5	NULL
)	NULL
.	NULL

FDCP-hMPLS	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
for	NULL
various	NULL
times	NULL
and	NULL
were	NULL
lysed	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
.	NULL

The	NULL
same	NULL
amount	NULL
of	NULL
a	NULL
95-kD	NULL
protein	NULL
recognized	NULL
by	NULL
Stat3	NULL
antisera	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
all	NULL
cellular	NULL
lysates	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

This	NULL
same	NULL
protein	NULL
became	NULL
tyrosine	NULL
phosphorylated	NULL
after	NULL
treatment	NULL
with	NULL
thrombopoietin	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
M	NULL
-_	NULL
L_	NULL
Epi	NULL
A	NULL
TPO	NULL
1min	NULL
L	NULL
J	NULL
lag	NULL
time	NULL
Jak2	NULL
was	NULL
tyrosine	NULL
phosphorylated	NULL
after	NULL
treatment	NULL
with	NULL
thrombopoietin	NULL
(	NULL
Fig	NULL
3C	NULL
)	NULL
,	NULL
which	NULL
corroborates	NULL
the	NULL
data	NULL
obtained	NULL
in	NULL
platelets	NULL
and	NULL
BaF3	NULL
cells	NULL
transfected	NULL
with	NULL
murine	NULL
c-Mpl	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
Furthermore	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
occurred	NULL
along	NULL
with	NULL
that	NULL
of	NULL
Stat3	NULL
(	NULL
compare	NULL
Fig	NULL
3A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
4G10	NULL
immunoprecipitates	NULL
contained	NULL
increased	NULL
amounts	NULL
of	NULL
Stat5	NULL
and	NULL
Jak2	NULL
from	NULL
lysates	NULL
of	NULL
FDCP-hMPLS	NULL
cells	NULL
(	NULL
Fig	NULL
3D	NULL
and	NULL
E	NULL
)	NULL
after	NULL
thrombopoietin	NULL
stimulation	NULL
.	NULL

As	NULL
in	NULL
platelets	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
or	NULL
Stat2	NULL
either	NULL
before	NULL
or	NULL
after	NULL
stimulation	NULL
of	NULL
FDCP-hMPLS	NULL
cells	NULL
with	NULL
thrombopoietin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
structural	NULL
similarity	NULL
between	NULL
thrombopoietin	NULL
and	NULL
erythropoietin	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
whether	NULL
Stat3	NULL
and	NULL
Stat5	NULL
were	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
FDCP-2	NULL
cells	NULL
expressing	NULL
erythropoietin	NULL
receptors	NULL
(	NULL
FD-ER3	NULL
cells	NULL
)	NULL
.	NULL

Erythropoietin	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat5	NULL
but	NULL
not	NULL
of	NULL
Stat3	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
4A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
treatment	NULL
of	NULL
platelets	NULL
with	NULL
thrombopoietin	NULL
enhances	NULL
aggregation	NULL
induced	NULL
by	NULL
various	NULL
agonists	NULL
such	NULL
as	NULL
shear	NULL
stress	NULL
,	NULL
epinephrine	NULL
,	NULL
and	NULL
ADP	NULL
(	NULL
manuscript	NULL
submitted	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
was	NULL
observed	NULL
at	NULL
1	NULL
ng/mL	NULL
of	NULL
thrombopoietin	NULL
and	NULL
reached	NULL
a	NULL
maximum	NULL
at	NULL
10	NULL
ng/ml	NULL
.	NULL

Figure	NULL
5A	NULL
shows	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

444	NULL
M.W	NULL
.	NULL

(	NULL
kDa	NULL
)	NULL
=-	NULL
200	NULL
wou	NULL
97.4	NULL
IP	NULL
:	NULL
:	NULL
anti-Tyk2	NULL
anti-PY	NULL
M.W	NULL
.	NULL

(	NULL
kDa	NULL
)	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
--	NULL
-	NULL
200	NULL
st	NULL
j—WA	NULL
IP	NULL
:	NULL
anti-Tyk2	NULL
WB	NULL
:	NULL
anti-Tyk2	NULL
Fig	NULL
6	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
in	NULL
platelets	NULL
stimulated	NULL
by	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

Platelets	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
before	NULL
and	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

Tyk2	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
anti-Tyk2	NULL
antisera	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
lysed	NULL
with	NULL
SDS-sample	NULL
buffer	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
onto	NULL
PVDF	NULL
membranes	NULL
.	NULL

Immunoblots	NULL
were	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
and	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
platelets	NULL
.	NULL

Lanes	NULL
2	NULL
through	NULL
5	NULL
,	NULL
15	NULL
seconds	NULL
,	NULL
1	NULL
minute	NULL
,	NULL
5	NULL
minutes	NULL
,	NULL
and	NULL
30	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
same	NULL
PVDF	NULL
membrane	NULL
used	NULL
in	NULL
(	NULL
A	NULL
)	NULL
was	NULL
stripped	NULL
of	NULL
the	NULL
antibody	NULL
and	NULL
reprobed	NULL
for	NULL
Tyk2	NULL
.	NULL

Bands	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
.	NULL

Lanes	NULL
are	NULL
the	NULL
same	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

B	NULL
Tyk2	NULL
-	NULL
>	NULL
»	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
also	NULL
occurs	NULL
at	NULL
1	NULL
ng/	NULL
mL	NULL
and	NULL
reached	NULL
a	NULL
maximum	NULL
at	NULL
10	NULL
ng/mL	NULL
.	NULL

We	NULL
found	NULL
that	NULL
epinephrine	NULL
,	NULL
which	NULL
does	NULL
not	NULL
induce	NULL
platelet	NULL
aggregation	NULL
in	NULL
hirudin-PRP	NULL
,	NULL
``	NULL
``	NULL
does	NULL
so	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
thrombopoietin	NULL
(	NULL
manuscript	NULL
submitted	NULL
)	NULL
.	NULL

Figure	NULL
5B	NULL
shows	NULL
that	NULL
thrombopoietin	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
did	NULL
not	NULL
induce	NULL
aggregation	NULL
or	NULL
shape	NULL
change	NULL
.	NULL

Subsequent	NULL
addition	NULL
of	NULL
epinephrine	NULL
induced	NULL
aggregation	NULL
within	NULL
15	NULL
seconds	NULL
.	NULL

When	NULL
the	NULL
order	NULL
of	NULL
the	NULL
agonists	NULL
was	NULL
re-versed	NULL
,	NULL
there	NULL
was	NULL
a	NULL
significant	NULL
lag	NULL
time	NULL
(	NULL
the	NULL
lower	NULL
line	NULL
)	NULL
.	NULL

However	NULL
,	NULL
aggregation	NULL
was	NULL
still	NULL
observed	NULL
within	NULL
1	NULL
minute	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
thrombopoietin	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
priming	NULL
of	NULL
epinephrine-induced	NULL
platelet	NULL
aggregation	NULL
occurred	NULL
within	NULL
1	NULL
minute	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
other	NULL
Jak	NULL
family	NULL
kinases	NULL
other	NULL
than	NULL
Jak2	NULL
may	NULL
also	NULL
be	NULL
tyrosine	NULL
phosphorylated	NULL
after	NULL
treatment	NULL
of	NULL
platelets	NULL
with	NULL
thrombopoietin	NULL
.	NULL

We	NULL
found	NULL
that	NULL
thrombopoietin	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
in	NULL
platelets	NULL
and	NULL
FDCP-hMPLS	NULL
cells	NULL
(	NULL
Figs	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
same	NULL
conditions	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
This	NULL
report	NULL
shows	NULL
the	NULL
presence	NULL
of	NULL
Stat	NULL
proteins	NULL
and	NULL
thrombopoietin-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
and	NULL
MIYAKAWA	NULL
ET	NULL
AL	NULL
Stat5	NULL
in	NULL
human	NULL
platelets	NULL
.	NULL

Both	NULL
were	NULL
also	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
FDCP-hMPLS	NULL
expressing	NULL
human	NULL
c-Mpl	NULL
,	NULL
a	NULL
receptor	NULL
for	NULL
thrombopoietin	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat	NULL
proteins	NULL
induced	NULL
by	NULL
thrombopoietin	NULL
was	NULL
apparently	NULL
limited	NULL
to	NULL
Stat3	NULL
and	NULL
Stat5	NULL
.	NULL

Our	NULL
data	NULL
do	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
other	NULL
unknown	NULL
Stat-like	NULL
proteins	NULL
are	NULL
also	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
platelets	NULL
or	NULL
in	NULL
FDCP-hMPLS	NULL
or	NULL
that	NULL
Stat1	NULL
or	NULL
Stat2	NULL
could	NULL
be	NULL
phosphorylated	NULL
below	NULL
the	NULL
level	NULL
of	NULL
detection	NULL
in	NULL
our	NULL
systems	NULL
.	NULL

Interestingly	NULL
,	NULL
Gurney	NULL
et	NULL
al	NULL
``	NULL
``	NULL
showed	NULL
that	NULL
Stat	NULL
1	NULL
and	NULL
3	NULL
were	NULL
activated	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
binding	NULL
to	NULL
a	NULL
sis-inducible	NULL
element	NULL
(	NULL
SIE	NULL
)	NULL
,	NULL
in	NULL
CMK	NULL
megakaryoblastoid	NULL
cells	NULL
stimulated	NULL
with	NULL
thrombopoietin	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
was	NULL
not	NULL
measured	NULL
directly	NULL
by	NULL
these	NULL
investigators	NULL
and	NULL
further	NULL
studies	NULL
will	NULL
be	NULL
required	NULL
to	NULL
explore	NULL
the	NULL
possibility	NULL
that	NULL
a	NULL
variety	NULL
of	NULL
Stat	NULL
heterodimers	NULL
are	NULL
formed	NULL
after	NULL
thrombopoietin	NULL
stimulation	NULL
.	NULL

In	NULL
a	NULL
study	NULL
by	NULL
Goullieux	NULL
et	NULL
al	NULL
,	NULL
``	NULL
it	NULL
was	NULL
also	NULL
reported	NULL
that	NULL
phosphorylation	NULL
of	NULL
tyrosine	NULL
at	NULL
position	NULL
697	NULL
was	NULL
essential	NULL
for	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
and	NULL
that	NULL
Stats	NULL
was	NULL
tyrosine	NULL
phosphorylated	NULL
by	NULL
Jak2	NULL
in	NULL
vitro	NULL
.	NULL

Our	NULL
data	NULL
show	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
occurred	NULL
along	NULL
with	NULL
that	NULL
of	NULL
Stat3	NULL
or	NULL
Stat5	NULL
.	NULL

Because	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
is	NULL
known	NULL
to	NULL
be	NULL
accompanied	NULL
by	NULL
enhanced	NULL
kinase	NULL
activity	NULL
,	NULL
``	NULL
``	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
Jak2	NULL
may	NULL
at	NULL
least	NULL
partially	NULL
contribute	NULL
to	NULL
tyrosine	NULL
phos-	NULL
M.W	NULL
.	NULL

(	NULL
kDa	NULL
)	NULL
--	NULL
=	NULL
300	NULL
w=	NULL
97.4	NULL
IP	NULL
:	NULL
anti-Tyk2	NULL
WB	NULL
:	NULL
anti-PY	NULL
M.wW	NULL
.	NULL

(	NULL
kDa	NULL
)	NULL
===	NULL
200	NULL
Tyk2	NULL
-	NULL
>	NULL
»	NULL
we	NULL
97,4	NULL
IP	NULL
:	NULL
anti-Tyk2	NULL
WB	NULL
:	NULL
anti-Tyk2	NULL
Fig	NULL
7	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
in	NULL
FDCP-hMPLS	NULL
cells	NULL
stimulated	NULL
by	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

FDCP-hMPLS5	NULL
cells	NULL
(	NULL
10	NULL
'	NULL
cells/mL	NULL
in	NULL
PBS	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
before	NULL
and	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

Tyk2	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
anti-Tyk2	NULL
antisera	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
lysed	NULL
with	NULL
SDS-sample	NULL
buffer	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
was	NULL
detected	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
1A	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
cells	NULL
.	NULL

Lanes	NULL
2	NULL
through	NULL
5	NULL
,	NULL
1	NULL
minute	NULL
,	NULL
5	NULL
minutes	NULL
,	NULL
10	NULL
minutes	NULL
,	NULL
and	NULL
30	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
thrombopoietin	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
same	NULL
PVDF	NULL
membrane	NULL
used	NULL
in	NULL
(	NULL
A	NULL
)	NULL
was	NULL
stripped	NULL
of	NULL
the	NULL
antibody	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Tyk2	NULL
antisera	NULL
.	NULL

Bands	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
.	NULL

Lanes	NULL
are	NULL
the	NULL
same	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

PLATELETS	NULL
AND	NULL
STAT	NULL
PROTEINS	NULL
phorylation	NULL
of	NULL
the	NULL
Stat	NULL
proteins	NULL
in	NULL
our	NULL
system	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
report	NULL
of	NULL
Rodriguez-Linares	NULL
et	NULL
al	NULL
``	NULL
``	NULL
Tyk2	NULL
and	NULL
Jak1	NULL
are	NULL
also	NULL
present	NULL
in	NULL
human	NULL
blood	NULL
platelets	NULL
and	NULL
that	NULL
Tyk2	NULL
becomes	NULL
tyrosine	NULL
phosphorylated	NULL
after	NULL
stimulation	NULL
of	NULL
platelets	NULL
and	NULL
FDCP-hMPLS	NULL
cells	NULL
with	NULL
thrombopoietin	NULL
(	NULL
Figs	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Tyk2	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
Stat	NULL
proteins	NULL
in	NULL
our	NULL
system	NULL
.	NULL

Recently	NULL
,	NULL
Sattler	NULL
et	NULL
al	NULL
``	NULL
``	NULL
also	NULL
reported	NULL
that	NULL
thrombopoietin	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
in	NULL
Mo7e	NULL
cells	NULL
and	NULL
BaF3	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
genetically	NULL
engineered	NULL
to	NULL
express	NULL
c-Mpl	NULL
,	NULL
although	NULL
Tortolani	NULL
et	NULL
al	NULL
``	NULL
``	NULL
did	NULL
not	NULL
detect	NULL
increased	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
in	NULL
thrombopoietin-treated	NULL
Mo7e	NULL
cells	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
the	NULL
different	NULL
observations	NULL
is	NULL
unknown	NULL
.	NULL

Involvement	NULL
of	NULL
both	NULL
Stat3	NULL
and	NULL
Stat5	NULL
in	NULL
signaling	NULL
induced	NULL
by	NULL
thrombopoietin	NULL
is	NULL
interesting	NULL
in	NULL
view	NULL
of	NULL
the	NULL
recent	NULL
reports	NULL
of	NULL
activation	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat5	NULL
but	NULL
not	NULL
of	NULL
Stat3	NULL
induced	NULL
by	NULL
erythropoietin	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
,	NULL
growth	NULL
hormone	NULL
,	NULL
and	NULL
GM-CSF	NULL
.	NULL
``	NULL

Indeed	NULL
,	NULL
Stahl	NULL
et	NULL
al	NULL
``	NULL
determined	NULL
that	NULL
the	NULL
YXXQ	NULL
motif	NULL
in	NULL
gp130	NULL
of	NULL
IL-6	NULL
receptor	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
Stat3	NULL
,	NULL
is	NULL
absent	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
erythropoietin	NULL
or	NULL
GM-CSF	NULL
receptor	NULL
.	NULL

This	NULL
motif	NULL
is	NULL
present	NULL
in	NULL
the	NULL
c-Mpl	NULL
cDNA	NULL
used	NULL
in	NULL
our	NULL
transfection	NULL
studies	NULL
.	NULL
``	NULL

Given	NULL
that	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
used	NULL
by	NULL
these	NULL
cytokines	NULL
overlap	NULL
significantly	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
specific	NULL
combinations	NULL
of	NULL
Jak	NULL
family	NULL
members	NULL
and	NULL
Stat	NULL
proteins	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
unique	NULL
effects	NULL
of	NULL
each	NULL
cytokine	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
thrombin	NULL
and	NULL
thrombopoietin	NULL
induced	NULL
distinctively	NULL
different	NULL
patterns	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
platelets	NULL
.	NULL
``	NULL

Although	NULL
Jak2	NULL
may	NULL
be	NULL
tyrosine	NULL
phosphorylated	NULL
and	NULL
activated	NULL
by	NULL
a	NULL
few	NULL
fold	NULL
in	NULL
thrombin-stimulated	NULL
platelets	NULL
,	NULL
``	NULL
we	NULL
did	NULL
not	NULL
find	NULL
measurable	NULL
increase	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
or	NULL
StatS5	NULL
proteins	NULL
after	NULL
thrombin	NULL
treatment	NULL
of	NULL
platelets	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
thrombin	NULL
receptor	NULL
and	NULL
c-Mpl	NULL
appear	NULL
to	NULL
use	NULL
differing	NULL
signaling	NULL
pathways	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
Stat	NULL
proteins	NULL
seems	NULL
to	NULL
be	NULL
unique	NULL
to	NULL
the	NULL
thrombopotetin	NULL
receptor	NULL
activation	NULL
in	NULL
platelets	NULL
.	NULL

One	NULL
of	NULL
the	NULL
most	NULL
interesting	NULL
findings	NULL
in	NULL
this	NULL
study	NULL
is	NULL
the	NULL
presence	NULL
of	NULL
Stat	NULL
proteins	NULL
in	NULL
human	NULL
platelets	NULL
because	NULL
they	NULL
are	NULL
devoid	NULL
of	NULL
nuclei	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
they	NULL
are	NULL
simply	NULL
remnants	NULL
from	NULL
megakaryocytes	NULL
.	NULL

However	NULL
,	NULL
this	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
a	NULL
role	NULL
for	NULL
Stat	NULL
proteins	NULL
in	NULL
megakaryopoiesis/thrombo-poiesis	NULL
.	NULL

Another	NULL
more	NULL
intriguing	NULL
hypothesis	NULL
is	NULL
that	NULL
Stat	NULL
proteins	NULL
may	NULL
have	NULL
roles	NULL
in	NULL
platelet	NULL
activation	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
found	NULL
that	NULL
thrombopoietin-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
was	NULL
observed	NULL
at	NULL
concentrations	NULL
of	NULL
thrombopoietin	NULL
of	NULL
1	NULL
ng/mL	NULL
and	NULL
reached	NULL
a	NULL
maximum	NULL
at	NULL
10	NULL
ng/mL	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

In	NULL
separate	NULL
experiments	NULL
,	NULL
we	NULL
found	NULL
that	NULL
thrombopoietin	NULL
primed	NULL
platelet	NULL
aggregation	NULL
induced	NULL
by	NULL
various	NULL
agonists	NULL
in	NULL
a	NULL
similar	NULL
dose	NULL
range	NULL
(	NULL
manuscript	NULL
submitted	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
priming	NULL
of	NULL
epinephrine-induced	NULL
platelet	NULL
aggregation	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
and	NULL
Stat5	NULL
occurred	NULL
within	NULL
1	NULL
minute	NULL
after	NULL
stimulation	NULL
of	NULL
platelets	NULL
with	NULL
thrombopoietin	NULL
(	NULL
compare	NULL
Figs	NULL
1A	NULL
,	NULL
2A	NULL
,	NULL
and	NULL
5B	NULL
)	NULL
.	NULL

Because	NULL
serum	NULL
levels	NULL
of	NULL
thrombopoietin	NULL
may	NULL
reach	NULL
10	NULL
ng/mL	NULL
in	NULL
thrombocytopenic	NULL
patients	NULL
,	NULL
``	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
and	NULL
Stats	NULL
and	NULL
priming	NULL
of	NULL
platelet	NULL
aggregation	NULL
by	NULL
thrombopoietin	NULL
occurred	NULL
in	NULL
a	NULL
similar	NULL
time	NULL
framework	NULL
and	NULL
in	NULL
a	NULL
dose	NULL
range	NULL
that	NULL
445	NULL
can	NULL
be	NULL
achieved	NULL
in	NULL
pathophysiologic	NULL
states	NULL
.	NULL

Because	NULL
thrombopoietin	NULL
may	NULL
enhance	NULL
the	NULL
activation	NULL
of	NULL
platelets	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
Stat	NULL
proteins	NULL
,	NULL
perhaps	NULL
through	NULL
their	NULL
SH2	NULL
domains	NULL
,	NULL
could	NULL
be	NULL
an	NULL
element	NULL
in	NULL
this	NULL
enhancement	NULL
.	NULL

Most	NULL
importantly	NULL
,	NULL
these	NULL
data	NULL
show	NULL
that	NULL
thrombopoietin	NULL
is	NULL
similar	NULL
to	NULL
other	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
G-CSF	NULL
,	NULL
that	NULL
are	NULL
not	NULL
only	NULL
required	NULL
for	NULL
the	NULL
proliferation	NULL
and	NULL
maturation	NULL
of	NULL
progenitor	NULL
cells	NULL
but	NULL
stimulate	NULL
the	NULL
functions	NULL
of	NULL
mature	NULL
hematopoietic	NULL
cells	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Dr	NULL
Arinobu	NULL
Tojo	NULL
,	NULL
Japan	NULL
Energy	NULL
Co	NULL
,	NULL
and	NULL
Amgen	NULL
Inc	NULL
for	NULL
kindly	NULL
providing	NULL
reagents	NULL
or	NULL
cells	NULL
.	NULL

We	NULL
thank	NULL
Akihiko	NULL
Shimosaka	NULL
for	NULL
his	NULL
continual	NULL
encouragement	NULL
and	NULL
helpful	NULL
comments	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Kaushansky	NULL
K	NULL
,	NULL
Lok	NULL
S	NULL
,	NULL
Holly	NULL
RD	NULL
,	NULL
Broudy	NULL
VC	NULL
,	NULL
Lin	NULL
N	NULL
,	NULL
Bailey	NULL
MC	NULL
,	NULL
Forstrom	NULL
JW	NULL
,	NULL
Buddle	NULL
MM	NULL
,	NULL
Oort	NULL
PJ	NULL
,	NULL
Hagen	NULL
FS	NULL
,	NULL
Roth	NULL
GJ	NULL
,	NULL
Papa-yannopoulou	NULL
T	NULL
,	NULL
Foster	NULL
DC	NULL
:	NULL
Promotion	NULL
of	NULL
megakaryocyte	NULL
progenitor	NULL
expansion	NULL
and	NULL
differentiation	NULL
by	NULL
the	NULL
c-Mpl	NULL
ligand	NULL
thrombopoietin	NULL
.	NULL

Nature	NULL
369:568	NULL
,	NULL
1994	NULL
2	NULL
.	NULL

Lok	NULL
S	NULL
,	NULL
Kaushansky	NULL
K	NULL
,	NULL
Holly	NULL
RD	NULL
,	NULL
Kuijper	NULL
JL	NULL
,	NULL
Lofton-Day	NULL
CE	NULL
,	NULL
Oort	NULL
PJ	NULL
,	NULL
Grant	NULL
FJ	NULL
,	NULL
Heipel	NULL
MD	NULL
,	NULL
Burkhead	NULL
SK	NULL
,	NULL
Kramer	NULL
JM	NULL
,	NULL
Bell	NULL
LA	NULL
,	NULL
Sprecher	NULL
CA	NULL
,	NULL
Blumberg	NULL
H	NULL
,	NULL
Johnson	NULL
R	NULL
,	NULL
Prunkard	NULL
D	NULL
,	NULL
Ching	NULL
AFT	NULL
,	NULL
Mathewes	NULL
SL	NULL
,	NULL
Bailey	NULL
MC	NULL
,	NULL
Forstrom	NULL
JW	NULL
,	NULL
Buddle	NULL
MM	NULL
,	NULL
Osborn	NULL
SG	NULL
,	NULL
Evans	NULL
SJ	NULL
,	NULL
Sheppard	NULL
PO	NULL
,	NULL
Presnell	NULL
SR	NULL
,	NULL
O'Hara	NULL
PJ	NULL
,	NULL
Hagen	NULL
FS	NULL
,	NULL
Roth	NULL
GJ	NULL
,	NULL
Foster	NULL
DC	NULL
:	NULL
Cloning	NULL
and	NULL
expression	NULL
of	NULL
murine	NULL
thrombopoietin	NULL
cDNA	NULL
and	NULL
stimulation	NULL
of	NULL
platelet	NULL
production	NULL
in	NULL
vivo	NULL
.	NULL

Nature	NULL
369:565	NULL
,	NULL
1994	NULL
3	NULL
.	NULL

Sohma	NULL
Y	NULL
,	NULL
Akahori	NULL
H	NULL
,	NULL
Seki	NULL
N	NULL
,	NULL
Hori	NULL
T	NULL
,	NULL
Ogami	NULL
K	NULL
,	NULL
Kato	NULL
T	NULL
,	NULL
Shimada	NULL
Y	NULL
,	NULL
Kawamura	NULL
K	NULL
,	NULL
Miyazaki	NULL
H	NULL
:	NULL
Molecular	NULL
cloning	NULL
and	NULL
chromosomal	NULL
localization	NULL
of	NULL
the	NULL
human	NULL
thrombopoietin	NULL
gene	NULL
.	NULL

FEBS	NULL
Lett	NULL
353:57	NULL
,	NULL
1994	NULL
4	NULL
.	NULL

Bartley	NULL
TD	NULL
,	NULL
Bogenberger	NULL
J	NULL
,	NULL
Hunt	NULL
P	NULL
,	NULL
Li	NULL
YS	NULL
,	NULL
Lu	NULL
HS	NULL
,	NULL
Martin	NULL
F	NULL
,	NULL
Chang	NULL
MS	NULL
,	NULL
Samal	NULL
B	NULL
,	NULL
Nichol	NULL
JL	NULL
,	NULL
Swift	NULL
S	NULL
,	NULL
Johnson	NULL
MJ	NULL
,	NULL
Hsu	NULL
RY	NULL
,	NULL
Parker	NULL
VP	NULL
,	NULL
Suggs	NULL
S	NULL
,	NULL
Skrine	NULL
JD	NULL
,	NULL
Merewether	NULL
LA	NULL
,	NULL
Clogston	NULL
C	NULL
,	NULL
Hsu	NULL
E	NULL
,	NULL
Hokom	NULL
MM	NULL
,	NULL
Hornkohl	NULL
A	NULL
,	NULL
Choi	NULL
E	NULL
,	NULL
Pangelinan	NULL
M	NULL
,	NULL
Sun	NULL
Y	NULL
,	NULL
Mar	NULL
V	NULL
,	NULL
McNinch	NULL
J	NULL
,	NULL
Simonet	NULL
L	NULL
,	NULL
Jacobsen	NULL
F	NULL
,	NULL
Xie	NULL
C	NULL
,	NULL
Shutter	NULL
J	NULL
,	NULL
Chute	NULL
H	NULL
,	NULL
Basu	NULL
R	NULL
,	NULL
Selander	NULL
L	NULL
,	NULL
Trollinger	NULL
D	NULL
,	NULL
Sieu	NULL
L	NULL
,	NULL
Padilla	NULL
D	NULL
,	NULL
Trail	NULL
G	NULL
,	NULL
Elliott	NULL
G	NULL
,	NULL
Izumi	NULL
R	NULL
,	NULL
Covey	NULL
T	NULL
,	NULL
Crouse	NULL
J	NULL
,	NULL
Garcia	NULL
A	NULL
,	NULL
Xu	NULL
W	NULL
,	NULL
Castillo	NULL
JD	NULL
,	NULL
Biron	NULL
J	NULL
,	NULL
Cole	NULL
S	NULL
,	NULL
Hu	NULL
MCT	NULL
,	NULL
Pacifici	NULL
R	NULL
,	NULL
Ponting	NULL
I	NULL
,	NULL
Saris	NULL
C	NULL
,	NULL
Wen	NULL
D	NULL
,	NULL
Yung	NULL
YP	NULL
,	NULL
Lin	NULL
H	NULL
,	NULL
Bosselman	NULL
RA	NULL
:	NULL
Identification	NULL
and	NULL
cloning	NULL
of	NULL
a	NULL
megakaryocyte	NULL
growth	NULL
and	NULL
development	NULL
factor	NULL
that	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
the	NULL
cytokine	NULL
receptor	NULL
Mpl	NULL
.	NULL

Cell	NULL
77:1117	NULL
,	NULL
1994	NULL
5.	NULL
de	NULL
Sauvage	NULL
FJ	NULL
,	NULL
Hass	NULL
PE	NULL
,	NULL
Spencer	NULL
SD	NULL
,	NULL
Malloy	NULL
BE	NULL
,	NULL
Gurney	NULL
AL	NULL
,	NULL
Spencer	NULL
SA	NULL
,	NULL
Darbonne	NULL
WC	NULL
,	NULL
Henzel	NULL
WJ	NULL
,	NULL
Wong	NULL
SC	NULL
,	NULL
Kuang	NULL
WJ	NULL
,	NULL
Oles	NULL
KJ	NULL
,	NULL
Hultgren	NULL
B	NULL
,	NULL
Lolberg	NULL
LA	NULL
Jr	NULL
,	NULL
Goeddel	NULL
DV	NULL
,	NULL
Eaton	NULL
DL	NULL
:	NULL
Stimulation	NULL
of	NULL
megakaryocytopoiesis	NULL
and	NULL
thrombopoiesis	NULL
by	NULL
the	NULL
c-Mpl	NULL
ligand	NULL
.	NULL

Nature	NULL
369:533	NULL
,	NULL
1994	NULL
6	NULL
.	NULL

Vigon	NULL
I	NULL
,	NULL
Mornon	NULL
JP	NULL
,	NULL
Cocault	NULL
L	NULL
,	NULL
Mitjavila	NULL
MT	NULL
,	NULL
Tambourin	NULL
P.	NULL
,	NULL
Gisselbrecht	NULL
S	NULL
,	NULL
Souyri	NULL
M	NULL
:	NULL
Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
MPL	NULL
,	NULL
the	NULL
human	NULL
homolog	NULL
of	NULL
the	NULL
v-mpl	NULL
oncogene	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
member	NULL
of	NULL
the	NULL
hematopoietic	NULL
growth	NULL
factor	NULL
receptor	NULL
superfamily	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:5640	NULL
,	NULL
1992	NULL
7	NULL
.	NULL

Vigon	NULL
I	NULL
,	NULL
Florindo	NULL
C	NULL
,	NULL
Fichelson	NULL
S	NULL
,	NULL
Guenet	NULL
JL	NULL
,	NULL
Mattei	NULL
MG	NULL
,	NULL
Souyri	NULL
M	NULL
,	NULL
Cosman	NULL
D	NULL
,	NULL
Gisselbrecht	NULL
S	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
murine	NULL
Mpl	NULL
proto-oncogene	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
hematopoietic	NULL
cytokine	NULL
receptor	NULL
family	NULL
:	NULL
Molecular	NULL
cloning	NULL
,	NULL
chromosomal	NULL
location	NULL
and	NULL
evidence	NULL
for	NULL
a	NULL
function	NULL
in	NULL
cell	NULL
growth	NULL
.	NULL

Oncogene	NULL
8:2607	NULL
,	NULL
1993	NULL
8	NULL
.	NULL

Kato	NULL
T	NULL
,	NULL
Ogami	NULL
K	NULL
,	NULL
Shimada	NULL
Y	NULL
,	NULL
Iwamatsu	NULL
A	NULL
,	NULL
Sohma	NULL
Y	NULL
,	NULL
Akahori	NULL
H	NULL
,	NULL
Horie	NULL
K	NULL
,	NULL
Kokubu	NULL
A	NULL
,	NULL
Kudo	NULL
Y	NULL
,	NULL
Maeda	NULL
E	NULL
,	NULL
Kobayashi	NULL
K	NULL
,	NULL
Ohashi	NULL
H	NULL
,	NULL
Ozawa	NULL
T	NULL
,	NULL
Inoue	NULL
H	NULL
,	NULL
Kawamura	NULL
K	NULL
,	NULL
Miyazaiki	NULL
H	NULL
:	NULL
Purification	NULL
and	NULL
characterization	NULL
of	NULL
thrombopoietin	NULL
.	NULL

J	NULL
Biochem	NULL
118:229	NULL
,	NULL
1995	NULL
9	NULL
.	NULL

Methia	NULL
N	NULL
,	NULL
Louache	NULL
F	NULL
,	NULL
Vainchenker	NULL
W	NULL
,	NULL
Wendling	NULL
F	NULL
:	NULL
Oligo-deoxynucleotides	NULL
antisense	NULL
to	NULL
the	NULL
proto-oncogene	NULL
c-mpl	NULL
specifically	NULL
inhibit	NULL
in	NULL
vitro	NULL
megakaryocytopoiesis	NULL
.	NULL

Blood	NULL
82:1395	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

446	NULL
10	NULL
.	NULL

Esther	NULL
SC	NULL
,	NULL
Nichol	NULL
JL	NULL
,	NULL
Hokom	NULL
MM	NULL
,	NULL
Hornkohl	NULL
AC	NULL
,	NULL
Hunt	NULL
P	NULL
:	NULL
Platelets	NULL
generated	NULL
in	NULL
vitro	NULL
from	NULL
proplatelet-displaying	NULL
human	NULL
mega-karyocytes	NULL
are	NULL
functional	NULL
.	NULL

Blood	NULL
85:402	NULL
,	NULL
1995	NULL
11	NULL
.	NULL

Kaushansky	NULL
K	NULL
,	NULL
Broudy	NULL
VC	NULL
,	NULL
Lin	NULL
N	NULL
,	NULL
Jorgensen	NULL
MJ	NULL
,	NULL
McCarty	NULL
J	NULL
,	NULL
Fox	NULL
N	NULL
,	NULL
Zucker-Franklin	NULL
D	NULL
,	NULL
Lofton-Day	NULL
C	NULL
:	NULL
Thrombopoietin	NULL
,	NULL
the	NULL
Mp	NULL
!	NULL

ligand	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
full	NULL
megakaryocyte	NULL
development	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:3234	NULL
,	NULL
1995	NULL
12	NULL
.	NULL

Debili	NULL
N	NULL
,	NULL
Wendling	NULL
F	NULL
,	NULL
Cosman	NULL
D	NULL
,	NULL
Titeux	NULL
M	NULL
,	NULL
Floorindo	NULL
C	NULL
,	NULL
Dusanter-Fourt	NULL
I	NULL
,	NULL
Schooley	NULL
K	NULL
,	NULL
Methia	NULL
N	NULL
,	NULL
Charon	NULL
M	NULL
,	NULL
Nador	NULL
R	NULL
,	NULL
Bet-taieb	NULL
A	NULL
,	NULL
Vainchenker	NULL
W	NULL
:	NULL
The	NULL
Mpl	NULL
ceceptor	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
megakaryocytic	NULL
lineage	NULL
from	NULL
late	NULL
progenitors	NULL
to	NULL
platelets	NULL
.	NULL

Blood	NULL
85:391	NULL
,	NULL
1995	NULL
13	NULL
.	NULL

Gurney	NULL
AL	NULL
,	NULL
Carver-Moore	NULL
K	NULL
,	NULL
de-Sauvage	NULL
FJ	NULL
,	NULL
Moore	NULL
MW	NULL
:	NULL
Thrombocytopenia	NULL
in	NULL
c-mpl-deficient	NULL
mice	NULL
.	NULL

Science	NULL
265:1445	NULL
,	NULL
1994	NULL
14	NULL
.	NULL

Drachman	NULL
JG	NULL
,	NULL
Griffin	NULL
JD	NULL
,	NULL
Kaushansky	NULL
K	NULL
:	NULL
The	NULL
c-mpl	NULL
ligand	NULL
(	NULL
thrombopoietin	NULL
)	NULL
stimulates	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
,	NULL
Shc	NULL
,	NULL
and	NULL
c-Mpl	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:4979	NULL
,	NULL
1995	NULL
15	NULL
.	NULL

Miyakawa	NULL
Y	NULL
,	NULL
Oda	NULL
A	NULL
,	NULL
Druker	NULL
BJ	NULL
,	NULL
Kato	NULL
T	NULL
,	NULL
Miyazaki	NULL
H	NULL
,	NULL
Handa	NULL
M	NULL
,	NULL
Ikeda	NULL
Y	NULL
:	NULL
Recombinant	NULL
thrombopoietin	NULL
induces	NULL
rapid	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Janus	NULL
kinase	NULL
2	NULL
and	NULL
Shc	NULL
in	NULL
human	NULL
blood	NULL
platelets	NULL
.	NULL

Blood	NULL
86:23	NULL
,	NULL
1995	NULL
16	NULL
.	NULL

Darnell	NULL
JE	NULL
Jr	NULL
,	NULL
Ian	NULL
M	NULL
,	NULL
Stark	NULL
GR	NULL
:	NULL
Jak-Stat	NULL
pathways	NULL
and	NULL
tran-scriptional	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IFNs	NULL
and	NULL
other	NULL
extracellular	NULL
signaling	NULL
proteins	NULL
.	NULL

Science	NULL
268:1415	NULL
,	NULL
1994	NULL
17	NULL
.	NULL

Thie	NULL
JN	NULL
,	NULL
Kerr	NULL
IM	NULL
:	NULL
Jaks	NULL
and	NULL
Stats	NULL
in	NULL
signaling	NULL
by	NULL
the	NULL
cytokine	NULL
receptor	NULL
superfamily	NULL
.	NULL

Trends	NULL
Genet	NULL
11:69	NULL
,	NULL
1995	NULL
18	NULL
.	NULL

Taniguchi	NULL
T	NULL
:	NULL
Cytokine	NULL
signaling	NULL
through	NULL
non	NULL
receptor	NULL
kinases	NULL
.	NULL

Science	NULL
268:251	NULL
,	NULL
1995	NULL
19	NULL
.	NULL

Oda	NULL
A	NULL
,	NULL
Druker	NULL
BJ	NULL
,	NULL
Smith	NULL
M	NULL
,	NULL
Salzman	NULL
EW	NULL
:	NULL
Inhibition	NULL
by	NULL
sodium	NULL
nitroprusside	NULL
or	NULL
PGE	NULL
,	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
induced	NULL
in	NULL
platelets	NULL
by	NULL
thrombin	NULL
or	NULL
ADP	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
262:701	NULL
,	NULL
1992	NULL
20	NULL
.	NULL

Oda	NULL
A	NULL
,	NULL
Druker	NULL
BJ	NULL
,	NULL
Smith	NULL
M	NULL
,	NULL
Salzman	NULL
EW	NULL
:	NULL
Association	NULL
of	NULL
pp6Osre	NULL
with	NULL
Triton	NULL
X-100-insoluble	NULL
residue	NULL
in	NULL
human	NULL
blood	NULL
platelets	NULL
requires	NULL
platelet	NULL
aggregation	NULL
and	NULL
actin	NULL
polymerization	NULL
[	NULL
published	NULL
erratum	NULL
appears	NULL
in	NULL
J	NULL
Biol	NULL
Chem	NULL
268:5339	NULL
,	NULL
1993	NULL
]	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:20075	NULL
,	NULL
1992	NULL
21	NULL
.	NULL

Dexter	NULL
TM	NULL
,	NULL
Garland	NULL
J	NULL
,	NULL
Scott	NULL
D	NULL
,	NULL
Scolnick	NULL
E	NULL
,	NULL
Metcalf	NULL
D	NULL
:	NULL
Growth	NULL
of	NULL
factor-dependent	NULL
hematopoietic	NULL
precursor	NULL
cell	NULL
lines	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
152:1036	NULL
,	NULL
1980	NULL
22	NULL
.	NULL

Ohashi	NULL
H	NULL
,	NULL
Maruyama	NULL
K	NULL
,	NULL
Lin	NULL
Y-C	NULL
,	NULL
Yoshimura	NULL
A	NULL
:	NULL
Ligand-induced	NULL
activation	NULL
of	NULL
chimeric	NULL
receptors	NULL
between	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
and	NULL
receptor	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:158	NULL
,	NULL
1994	NULL
23	NULL
.	NULL

Laemmli	NULL
UK	NULL
:	NULL
Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
227:680	NULL
,	NULL
1970	NULL
24	NULL
.	NULL

Gouilleux	NULL
F	NULL
,	NULL
Wakao	NULL
H	NULL
,	NULL
Mundt	NULL
M	NULL
,	NULL
Groner	NULL
B	NULL
:	NULL
Prolactin	NULL
induces	NULL
MIYAKAWA	NULL
ET	NULL
AL	NULL
phosphorylation	NULL
of	NULL
Tyr694	NULL
of	NULL
Stat5	NULL
(	NULL
MGF	NULL
)	NULL
,	NULL
a	NULL
prerequisite	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
induction	NULL
of	NULL
transcription	NULL
.	NULL

EMBO	NULL
J	NULL
13:4361	NULL
,	NULL
1994	NULL
25	NULL
.	NULL

Lalau-Keraly	NULL
C	NULL
,	NULL
Kinlough-Rathbone	NULL
RL	NULL
,	NULL
Packham	NULL
MA	NULL
,	NULL
Suzuki	NULL
H	NULL
,	NULL
Mustard	NULL
JF	NULL
:	NULL
Conditions	NULL
affecting	NULL
the	NULL
responses	NULL
of	NULL
human	NULL
platelets	NULL
to	NULL
epinephrine	NULL
.	NULL

Thromb	NULL
Haemost	NULL
60:209	NULL
,	NULL
1988	NULL
26	NULL
.	NULL

Gurney	NULL
AL	NULL
,	NULL
Wong	NULL
SC	NULL
,	NULL
Henzel	NULL
WJ	NULL
,	NULL
de	NULL
Sauvage	NULL
FJ	NULL
:	NULL
Distinct	NULL
regions	NULL
of	NULL
c-Mpl	NULL
cytoplasmic	NULL
domain	NULL
are	NULL
coupled	NULL
to	NULL
the	NULL
JAK-STAT	NULL
signal	NULL
transduction	NULL
pathway	NULL
and	NULL
She	NULL
phosphorylation	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:5292	NULL
,	NULL
1995	NULL
27	NULL
.	NULL

Rodriguez-Linares	NULL
B	NULL
,	NULL
Watson	NULL
SP	NULL
:	NULL
Phosphorylation	NULL
of	NULL
JAK2	NULL
in	NULL
thrombin-stimulated	NULL
human	NULL
platelets	NULL
.	NULL

FEBS	NULL
Lett	NULL
352:335	NULL
,	NULL
1994	NULL
28	NULL
.	NULL

Sattler	NULL
M	NULL
,	NULL
Dustin	NULL
MA	NULL
,	NULL
Frank	NULL
DA	NULL
,	NULL
Okuda	NULL
K	NULL
,	NULL
Kaushansky	NULL
K	NULL
,	NULL
Salgia	NULL
R	NULL
,	NULL
Griffin	NULL
JD	NULL
:	NULL
The	NULL
thrombopoietin	NULL
receptor	NULL
c-Mpl	NULL
activates	NULL
Jak2	NULL
and	NULL
Tyk2	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Exp	NULL
Hematol	NULL
23:1040	NULL
,	NULL
1995	NULL
29	NULL
.	NULL

Tortolani	NULL
PJ	NULL
,	NULL
Johnston	NULL
JA	NULL
,	NULL
Bacon	NULL
CM	NULL
,	NULL
McVicar	NULL
DM	NULL
,	NULL
Shimosaka	NULL
A	NULL
,	NULL
Linnekin	NULL
D	NULL
,	NULL
Longo	NULL
DL	NULL
,	NULL
O'Shea	NULL
JJ	NULL
;	NULL
Thrombopoietin	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
Janus	NULL
kinase	NULL
,	NULL
Jak2	NULL
.	NULL

Blood	NULL
85:3444	NULL
,	NULL
1995	NULL
30	NULL
.	NULL

Gouilleux	NULL
F	NULL
,	NULL
Pallard	NULL
C	NULL
,	NULL
Dusanter-Fourt	NULL
I	NULL
,	NULL
Wakao	NULL
H	NULL
,	NULL
Haldosen	NULL
LA	NULL
,	NULL
Norstedt	NULL
G	NULL
,	NULL
Levy	NULL
D	NULL
,	NULL
Groner	NULL
B	NULL
:	NULL
Prolactin	NULL
,	NULL
growth	NULL
hormone	NULL
,	NULL
erythropoietin	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
induce	NULL
MGF-Stat5	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

EMBO	NULL
J	NULL
14:2005	NULL
,	NULL
1995	NULL
31	NULL
.	NULL

Wakao	NULL
H	NULL
,	NULL
Harada	NULL
N	NULL
,	NULL
Kitamura	NULL
T	NULL
,	NULL
Mui	NULL
AL-F	NULL
,	NULL
Miyajima	NULL
A	NULL
:	NULL
Interleukin	NULL
2	NULL
and	NULL
erythropoietin	NULL
activate	NULL
STATS/MGF	NULL
via	NULL
distinct	NULL
pathways	NULL
.	NULL

EMBO	NULL
J	NULL
14:2527	NULL
,	NULL
1995	NULL
32	NULL
.	NULL

Stahl	NULL
N	NULL
,	NULL
Farruggella	NULL
,	NULL
Boulton	NULL
TG	NULL
,	NULL
Zhong	NULL
Z	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
,	NULL
Yancopoulous	NULL
GD	NULL
:	NULL
Choice	NULL
of	NULL
STAT	NULL
's	NULL
and	NULL
other	NULL
substrates	NULL
specified	NULL
by	NULL
modular	NULL
tyrosine-based	NULL
motifs	NULL
in	NULL
cytokine	NULL
receptors	NULL
.	NULL

Science	NULL
267:1349	NULL
,	NULL
1995	NULL
33	NULL
.	NULL

Witthuhn	NULL
BA	NULL
,	NULL
Quelle	NULL
FW	NULL
,	NULL
Silvennoinen	NULL
O	NULL
,	NULL
Yi	NULL
T	NULL
,	NULL
Tang	NULL
B	NULL
,	NULL
Miura	NULL
O	NULL
,	NULL
Ihle	NULL
JN	NULL
:	NULL
JAK2	NULL
associates	NULL
with	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
and	NULL
is	NULL
tyrosine	NULL
phosphorylated	NULL
and	NULL
activated	NULL
following	NULL
stimulation	NULL
with	NULL
erythropoietin	NULL
.	NULL

Cell	NULL
74:227	NULL
,	NULL
1993	NULL
34	NULL
.	NULL

Zhuang	NULL
H	NULL
,	NULL
Patel	NULL
SV	NULL
,	NULL
He	NULL
TC	NULL
,	NULL
Niu	NULL
Z	NULL
,	NULL
Wojchowski	NULL
DM	NULL
:	NULL
Dominant	NULL
negative	NULL
effects	NULL
of	NULL
a	NULL
carboxy-truncated	NULL
Jak2	NULL
mutant	NULL
on	NULL
Epo-induced	NULL
proliferation	NULL
and	NULL
Jak2	NULL
activation	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
204:278	NULL
,	NULL
1994	NULL
35	NULL
.	NULL

He	NULL
TC	NULL
,	NULL
Jiang	NULL
N	NULL
,	NULL
Zhuang	NULL
H	NULL
,	NULL
Quelle	NULL
DE	NULL
,	NULL
Wojchowski	NULL
DM	NULL
:	NULL
The	NULL
extended	NULL
box	NULL
2	NULL
subdomain	NULL
of	NULL
erythropoietin	NULL
receptor	NULL
is	NULL
nonessential	NULL
for	NULL
Jak2	NULL
activation	NULL
yet	NULL
critical	NULL
for	NULL
efficient	NULL
mitogenesis	NULL
in	NULL
FDC-ER	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:18291	NULL
,	NULL
1994	NULL
36	NULL
.	NULL

Ballmaier	NULL
M	NULL
,	NULL
Straub	NULL
G	NULL
,	NULL
Lynen	NULL
S	NULL
,	NULL
Bogenberger	NULL
J	NULL
,	NULL
Swift	NULL
S	NULL
,	NULL
Welte	NULL
K.	NULL
Expression	NULL
of	NULL
megakaryocyte	NULL
growth	NULL
and	NULL
development	NULL
factor	NULL
mRNA	NULL
in	NULL
human	NULL
tissues	NULL
and	NULL
detection	NULL
of	NULL
MGDF	NULL
in	NULL
sera	NULL
from	NULL
healthy	NULL
individuals	NULL
and	NULL
patients	NULL
with	NULL
thrombocyopenia	NULL
.	NULL

Exp	NULL
Hematol	NULL
23:823	NULL
,	NULL
1995	NULL
(	NULL
abstr	NULL
)	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blood	NULL
=	NULL
--	NULL
Thrombopoietin	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
and	NULL
Stat5	NULL
in	NULL
human	NULL
blood	NULL
platelets	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
Y	NULL
Miyakawa	NULL
,	NULL
A	NULL
Oda	NULL
,	NULL
BJ	NULL
Druker	NULL
,	NULL
H	NULL
Miyazaki	NULL
,	NULL
M	NULL
Handa	NULL
,	NULL
H	NULL
Ohashi	NULL
and	NULL
Y	NULL
Ikeda	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/87/2/439.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

